Cytovia cytovia.com


Public lists: Pharma Startups (4732)

Commercializes a patented drug screening technology through partnerships with large pharmaceutical companies and clinical testing service companies. Cytovia (NASDAQ: MAXM) was acquired by Maxim Pharmaceuticals, Inc. in June 2000.

Commercializes a patented drug screening technology through partnerships with large pharmaceutical companies and clinical testing service companies. Cytovia (NASDAQ: MAXM) was acquired by Maxim Pharmaceuticals, Inc. in June 2000.

Company (Acquired)

Phone: 858-860-0500

Fax:

6650 Nancy Ridge Drive

Irvine, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cytovia $15.4M Jun 21, 2000
Rapid Laboratory Microsystems $0M Nov 30, 2018
Active Pass Pharmaceuticals $0M Nov 30, 2018
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cytovia Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors